earnings
RM
NASDAQ · RMTI
Rockwell Medical, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$7.91
Up+$0.16 (+1.96%)
Updated Sep 18, 2026, 10:20 PM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 32.73M
- P/E ratio
- -6.23
- Dividend yield
- 0.00%
- 52-week range
- $0.60 – $8.50
- Volume
- 5.61K
- Avg. volume
- 636.92K
Price performance
RMTI price history
1M range · 20 trading sessions · Daily adjusted prices
RMTI closed at $7.91 after 20 trading sessions, up 3.53% for the selected period.
- Last close
- $7.91
- Period change
- +3.53%
- Period low
- $7.64
- Period high
- $8.31
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $7.89 | $7.91 | $7.8006 | $7.91 | 5.61K |
| Sep 16, 2026 | $7.85 | $7.90 | $7.7801 | $7.80 | 2.92K |
| Sep 15, 2026 | $7.699 | $7.96 | $7.699 | $7.85 | 6.47K |
| Sep 14, 2026 | $7.95 | $8.03 | $7.78 | $7.78 | 5.88K |
| Sep 11, 2026 | $7.87 | $8.34 | $7.87 | $7.96 | 42.75K |
| Sep 10, 2026 | $7.85 | $8.10 | $7.5106 | $8.04 | 36.51K |
| Sep 9, 2026 | $7.72 | $8.18 | $7.28 | $7.955 | 21.39K |
| Sep 8, 2026 | $7.93 | $8.11 | $7.50 | $8.06 | 33.18K |
| Sep 4, 2026 | $7.8992 | $8.09 | $7.7805 | $7.985 | 6.58K |
| Sep 3, 2026 | $7.91 | $8.06 | $7.85 | $7.985 | 5.43K |
| Sep 2, 2026 | $7.99 | $8.16 | $7.96 | $8.07 | 15.06K |
| Sep 1, 2026 | $8.28 | $8.2821 | $7.90 | $8.045 | 25.01K |
| Aug 31, 2026 | $8.12 | $8.50 | $7.79 | $8.31 | 48.76K |
| Aug 28, 2026 | $7.83 | $8.27 | $7.70 | $8.17 | 36.44K |
| Aug 27, 2026 | $7.93 | $8.06 | $7.75 | $7.75 | 5.92K |
| Aug 26, 2026 | $7.99 | $8.40 | $7.71 | $7.915 | 55.03K |
| Aug 25, 2026 | $7.87 | $8.09 | $7.71 | $7.945 | 6.96K |
| Aug 24, 2026 | $7.82 | $8.00 | $7.7743 | $7.90 | 15.17K |
| Aug 21, 2026 | $7.72 | $8.10 | $7.555 | $8.10 | 25.81K |
| Aug 20, 2026 | $7.50 | $7.80 | $7.50 | $7.64 | 50.25K |
Latest RMTI news
The latest Smart Investors Daily articles mentioning RMTI.
Stock researchCompany · Forecast
Loading stock research…